Leuconostoc mesenteroides with effect of relieving toxicity of plasticizer and application of leuconostoc mesenteroides

The adsorption of probiotic preparations of Aspergillus DM12 and the excretion of plasticizers is solved, the problem of plasticizer accumulation in the body is significantly reduced, and its toxicity damages to the reproductive organs and liver are restored to the healthy state of mice.

CN119020208APending Publication Date: 2024-11-26HENAN NORMAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411116498.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Long-term exposure to plasticizers such as dibutyl phthalate can lead to oxidative damage, neurotoxicity, liver toxicity, reproductive toxicity and embryonic toxicity. The prior art is difficult to effectively promote its excretion and reduce its accumulation in the body.

Method used

A strain of Aspergillus DM12 was used. This strain can be colonized in the intestine for a long time, adsorbed and promoted the discharge of plasticizers, and applied in the form of probiotic preparations, combined with other probiotics to enhance its effect.

Benefits of technology

It significantly reduces the accumulation of plasticizers in the body, reduces its damage to the reproductive organs and liver, restores the weight of mice, improves sperm density and morphology, and repairs physical damage caused by plasticizers, providing new ideas for maintaining health.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119020208A_ABST
    Figure CN119020208A_ABST
Patent Text Reader

Abstract

The invention discloses a Leuconostoc mesenteroides strain with a plasticizer toxicity relieving effect and application of the Leuconostoc mesenteroides strain, the Leuconostoc mesenteroides strain is classified and named as Leuconostoc mesenteroides and preserved in the China General Microbiological Culture Collection Center (CGMCC), and the preservation number is CGMCC NO.30178; the leuconostoc mesenteroides can grow on an MRS agar culture medium, the leuconostoc mesenteroides is gram-positive bacteria, the colonial morphology is round, and the surface is smooth and milky white. The screened leuconostoc mesenteroides can be colonized in intestinal tracts for a long time, has good probiotic characteristics, can adsorb plasticizers such as dibutyl phthalate, promotes the plasticizers such as dibutyl phthalate to be discharged along with excrement, and improves the immunity of the human body. Therefore, body injury caused by excessive accumulation of plasticizers such as dibutyl phthalate and the like in the body is prevented or relieved, and the method has important significance on maintaining the health of a host.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of plasticizer toxicity alleviation strains and biological preparations, and specifically relates to a strain of Leuconostoc mesenteroides capable of alleviating the toxicity of plasticizers and an application thereof. Background Art

[0002] With the acceleration of industrialization, the market demand for plasticizers continues to increase, and they are widely used in plastic additives, household products, food packaging, etc. Dibutylphthalate (DBP) is a type of plasticizer and a common pollutant in food. It can enter the human body through the digestive tract, skin, etc. from contaminated food and food packaging materials, and has an impact on human health. Long-term exposure to dibutyl phthalate can cause oxidative damage, neurotoxicity, liver toxicity, reproductive toxicity, and embryotoxicity. Therefore, how to promote the discharge of dibutyl phthalate in the body and reduce the damage caused by dibutyl phthalate has become a research hotspot.

[0003] Lactic acid bacteria are a group of Gram-positive microorganisms that can ferment lactose into lactic acid. They have beneficial functions such as promoting animal growth, regulating intestinal flora, improving gastrointestinal function, and increasing food digestibility and bioavailability. As an important species of the genus Leuconostoc among lactic acid bacteria, Leuconostoc mesenteroides can not only ferment sugars to produce a variety of acids and alcohols, but also has the ability to produce high acid, antioxidant and antagonize pathogenic bacteria. Leuconostoc mesenteroides can colonize in the intestines of mice and has a good adsorption effect on dibutyl phthalate. Therefore, it is feasible to use Leuconostoc mesenteroides to alleviate the biological toxicity caused by dibutyl phthalate, which is of great significance for regulating human intestinal flora, removing harmful substances in plasticizers, and maintaining body health. There are currently no relevant reports in this regard. Summary of the invention

[0004] The purpose of the present invention is to provide a strain of Leuconostoc mesenteroides that can alleviate the toxic effects of plasticizers and its application, wherein Leuconostoc mesenteroides DM12 can be colonized in the intestine for a long time, has good probiotic properties, can adsorb plasticizers such as dibutyl phthalate, and promote the excretion of plasticizers such as dibutyl phthalate with feces, thereby preventing or alleviating the body damage caused by excessive accumulation of plasticizers such as dibutyl phthalate in the body, which is of great significance for maintaining the health of the host.

[0005] The present invention adopts the following technical solution to solve the above technical problems: a strain of Leuconostoc mesenteroides having the ability to alleviate the toxicity of plasticizers, which is classified and named Leuconostoc mesenteroides and is deposited in the General Microbiology Center of the China Microbiological Culture Collection Administration with a deposit number of CGMCCNO.30178.

[0006] Furthermore, the Leuconostoc mesenteroides was isolated and purified from kimchi, and its 16srDNA sequence was shown as SEQ ID NO.1 in the sequence table.

[0007] Furthermore, the Leuconostoc mesenteroides can grow on MRS agar medium. The Leuconostoc mesenteroides is a Gram-positive bacterium with a round colony morphology, a smooth surface, and a milky white color. The optimal growth temperature is 37° C. and the culture time is 12 hours.

[0008] The Leuconostoc mesenteroides of the present invention is used in the preparation of a biological preparation for preventing or alleviating biological toxicity caused by plasticizers. The Leuconostoc mesenteroides can colonize in the body for a long time and is used to adsorb plasticizers in the body, promote the discharge of plasticizers in the body, reduce the accumulation of plasticizers in the body, and thus alleviate the biological toxicity of plasticizers.

[0009] Furthermore, the Leuconostoc mesenteroides can promote the excretion of plasticizers from the body, reduce the content of plasticizers in serum, significantly reduce the damage of plasticizers to reproductive organs and liver, and is used to repair body damage caused by plasticizers.

[0010] Furthermore, the plasticizer is one or more of dibutyl phthalate (DBP), di-2-ethylhexyl phthalate (DEHP), dimethyl phthalate (DMP), diisobutyl phthalate (DIBP), dioctyl phthalate (DOP), butyl benzyl phthalate (BBP); diisononyl phthalate (DINP) or diethyl phthalate (DEP).

[0011] Furthermore, the plasticizer is taken in from food.

[0012] Furthermore, the effective dose of dibutyl phthalate for Leuconostoc mesenteroides is 6 mg / kg / d.

[0013] Furthermore, the number of live bacteria used in the intestinal leuconostoc is 5×10 11 CFU / mL.

[0014] A probiotic preparation comprises the live bacteria of Leuconostoc mesenteroides and / or its fermentation product.

[0015] Furthermore, the probiotic preparation also contains one or more of Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus delbrueckii, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus helveticus, Streptococcus thermophilus, Lactobacillus rhamnosus, Lactobacillus paracasei, Lactobacillus salivarius, Leuconostoc lemon, Lactobacillus brevis, Bifidobacterium longum, Bifidobacterium infantis, Bifidobacterium breve, Bifidobacterium bifidum, Bacillus coagulans, Lactococcus, Lactobacillus crispatus, Lactobacillus reuteri, Lactobacillus casei, Pediococcus pentosaceus, Lactobacillus bulgaricus, Lactobacillus gasseri or Streptococcus thermophilus.

[0016] The present invention has the following advantages and beneficial effects:

[0017] The present invention uses Leuconostoc mesenteroides DM12 as the research object, exposes experimental animals to low doses of dibutyl phthalate, constructs a mouse model, and conducts intervention treatment, aiming to provide new ideas for the application of probiotics and the prevention and relief of biological toxicity caused by harmful substances such as plasticizers in the human body. The results show that the Leuconostoc mesenteroides DM12 provided by the present invention can restore the weight of mice to normal levels, promote the excretion of dibutyl phthalate with feces (excretion rate is 43.1%), and reduce accumulation in the body, thereby alleviating the toxicity of dibutyl phthalate to the reproductive organs and liver of mice. The Leuconostoc mesenteroides DM12 screened by the present invention is a safe strain that can effectively alleviate the biological toxicity caused by plasticizer exposure, and has high research value and application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 This is the growth curve of Leuconostoc mesenteroides under different concentrations of plasticizer DBP.

[0019] Figure 2 This is a colony picture of Leuconostoc mesenteroides DM12.

[0020] Figure 3 Leuconostoc mesenteroides DM12 alleviates the body weight changes of mice in the dibutyl phthalate toxicity experiment (different lowercase letters indicate significant differences, p<0.05).

[0021] Figure 4 This is the organ coefficient of mice in which Leuconostoc mesenteroides DM12 alleviates the toxicity of dibutyl phthalate (different lowercase letters indicate significant differences, p<0.05).

[0022] Figure 5 The dibutyl phthalate content in the serum and feces of mice and the average daily DBP excretion were determined in the experiment in which Leuconostoc mesenteroides DM12 alleviated the toxicity of dibutyl phthalate (different lowercase letters indicate significant differences, p<0.05).

[0023] Figure 6Leuconostoc mesenteroides DM12 alleviates the sperm density and sperm deformity rate of mice in the dibutyl phthalate toxicity experiment (different lowercase letters indicate significant differences, p<0.05).

[0024] Figure 7 This is a picture of the pathological section analysis of the reproductive organs of mice in the experiment in which Leuconostoc mesenteroides DM12 alleviated the toxicity of dibutyl phthalate.

[0025] Figure 8 This is a picture of the liver pathological section analysis of mice in the experiment where Leuconostoc mesenteroides DM12 alleviated the toxicity of dibutyl phthalate. DETAILED DESCRIPTION

[0026] The above contents of the present invention are further described in detail below by way of examples, but this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples, and all technologies realized based on the above contents of the present invention belong to the scope of the present invention. The reagents and instruments used without indicating the manufacturer are all conventional products purchased through regular commercial channels.

[0027] Example 1

[0028] Cultivation, isolation and screening of strains

[0029] 1. In vitro cultivation of bacterial strains capable of absorbing plasticizers

[0030] Prepare MRS (Man Rogosa Sharpe) liquid culture medium: 1000 mL of pure water, 10 g of peptone, 10 g of beef extract, 5.0 g of yeast extract, 5 g of sodium acetate, 5 g of glucose, 2 g of potassium dihydrogen phosphate, 1.0 mL of Tween 80, 2.0 g of diammonium citrate, 20 g of calcium carbonate, 0.58 g of magnesium sulfate, and 0.25 g of manganese sulfate, and adjust the pH of the mixed system to 6.2-6.5.

[0031] Prepare MRS solid culture medium: add 15-20g agar to 1000mL MRS liquid culture medium.

[0032] Take 1g of naturally fermented kimchi, dilute it with sterile saline, put it into a sterile sample bag, and beat it with a homogenizer to mix it; take 100μL of the mixed solution for gradient dilution, spread it on MRS agar medium, and culture it anaerobically at 37℃ for 36h, and wait for single colonies to grow on the plate for microscopic examination. According to the results of microscopic examination, the applicant screened out a total of 28 potential lactic acid bacteria strains, named DM1, DM2,..., DM28. Pick a single colony to expand the culture in liquid MRS culture medium, and further spread it for separation, 3-5 times of purification and separation, and finally obtain pure culture colonies of different forms; pick a single colony of pure culture in MRS liquid culture medium, and culture it at 37℃ overnight to obtain an isolated bacterial suspension, i.e., the initial screening bacterial suspension.

[0033] 2. Isolation and screening of strains capable of adsorbing plasticizers in vitro

[0034] 2.1 Preparation

[0035] Prepare plasticizer solution: Prepare 100 mg / mL plasticizer working solution with methanol. Dilute with sterile water to the required concentration before use.

[0036] Strain activation culture: Take out the lactic acid bacteria strains stored in vacuum freeze-drying, inoculate them into MRS liquid culture medium respectively, culture them at 37°C for 36 hours, and then activate them continuously for 2-3 times.

[0037] Preparation of bacterial suspension: centrifuge the culture solution of lactic acid bacteria strains (6000r / min, 4°C, 15min), collect the bacteria, wash them twice with sterile saline and resuspend them, and adjust the cell concentration of the strains to 5×10 11 CFU / mL.

[0038] 2.2 Tolerance test of strains to different concentrations of plasticizers

[0039] The plasticizer DBP was diluted with the strain culture medium to 0μg / mL, 10μg / mL, 20μg / mL, 30μg / mL, 40μg / mL, 50μg / mL, 60μg / mL, 70μg / mL, 80μg / mL, 90μg / mL, and 100μg / mL, and the lactic acid bacteria strains were inoculated at 4wt% inoculation respectively, and the growth curve of the strain was monitored by a growth curve analyzer. The results showed that the strain activity was not affected when the culture medium contained a low concentration of plasticizer DBP, and even slightly promoted the growth of the strain. When the content of plasticizer DBP in the culture medium was close to 40μg / mL, the strain activity was inhibited. At the same time, according to the data, the food hygiene standard stipulates that the content of plasticizer in food is 0.3mg / kg. Therefore, 10μg / mL can be used as the plasticizer addition concentration to verify the plasticizer adsorption capacity of the strain.

[0040] 2.3 Testing of the ability of strains to adsorb plasticizers

[0041] Determination of the efficiency of plasticizer adsorption by bacterial cells: Centrifuge 1 mL of lactic acid bacteria suspension at 4°C for 5 min (6000 r / min), then remove the supernatant, add 900 μL of sterile water and 100 μL of plasticizer working solution (100 mg / L), and finally obtain a 10 mg / L plasticizer suspension. Incubate the mixture at 37°C for 4 h, then centrifuge it for 10 min (3500 r / min), and collect the supernatant for later use. The content of plasticizer was quantitatively detected by high performance liquid chromatography, and the blank control was 1 mL of 10 mg / L plasticizer aqueous solution without lactic acid bacteria strains.

[0042] The adsorption rate of Lactobacillus to plasticizer is calculated as follows:

[0043] Adsorption rate (%) = [(the content of plasticizer in the blank sample - the content of plasticizer in the supernatant) / the content of plasticizer in the blank sample] × 100.

[0044] 2.4 Selection of plasticizer adsorption strains

[0045] The lactic acid bacteria strains DM1-DM28 were used to prepare bacterial suspensions of plasticizers DEP, DBP, DIBP, DOP, BBP and DEHP, respectively, and the adsorption rates of different types of plasticizers were measured respectively, and the strains with higher comprehensive adsorption capacity were selected.

[0046] The results showed that the strain DM12 had the highest plasticizer adsorption rate among the 28 potential lactic acid bacteria isolated, with a plasticizer adsorption rate of 90.08±3.83% within 4 hours and a plasticizer adsorption rate of 99.36±2.57% within 11 hours. The growth curve of strain DM12 in different concentrations of plasticizer DBP is shown in Figure 2. Figure 1 shown.

[0047] Example 2

[0048] Strain identification

[0049] 1. Colony morphology identification

[0050] The colony picture of strain DM12 inoculated on MRS agar medium is shown in Figure 1 As shown, the colonies are round, smooth and milky white.

[0051] 2. Molecular Biology Identification

[0052] The 16s rDNA sequence of strain DM12 was obtained by sequencing, and the sequence was compared with the NCBI database, confirming that the strain was Leuconostoc mesenteroides.

[0053] The specific sequence of 16s rDNA is as follows:

[0054] caagtcgaacgcacagcgaaaggtgcttgcacctttcaagtgagtggcgaacgggtgagtaacacgtggacaacctgcctca

[0055] aggctggggataacatttggaaacagatgctaataccgaataaaacttagtgtcgcatgacacaaagttaaaaggcgcttcggcgtcac

[0056] ctagagatggatccgcggtgcattagttagttggtggggtaaaggcctaccaagacaatgatgcatagccgagttgagagactgatcg

[0057] gccacattgggactgagacacggcccaaactcctacgggaggctgcagtagggaatcttccacaatgggcgaaagcctgatggagc

[0058] aacgccgcgtgtgtgatgaaggctttcgggtcgtaaagcactgttgtatgggaagaacagctagaataggaaatgattttagtttgacgg

[0059] taccataccagaaagggacggctaaatacgtgccagcagccgcggtaatacgtatgtcccgagcgttatccggatttattgggcgtaa

[0060] agcgagcgcagacggtttattaagtctgatgtgaaagcccggagctcaactccggaatggcattggaaactggttaacttgagtgcagt

[0061] agaggtaagtggaactccatgtgtagcggtggaatgcgtagatatatggaagaacaccagtggcgaaggcggcttactggactgcaa

[0062] ctgacgttgaggctcgaaagtgtgggtagcaaacaggattagataccctggtagtccacaccgtaaacgatgaacactaggtgttagg

[0063] aggtttccgcctcttagtgccgaagctaacgcattaagtgttccgcctggggagtacgaccgcaaggttgaaactcaaaggaattgacg

[0064] gggacccgcacaagcggtggagcatgtggtttaattcgaagcaacgcgaagaaccttaccaggtcttgacatcctttgaagcttttaga

[0065] gatagaagtgttctcttcggagacaaagtgacaggtggtgcatggtcgtcgtcagctcgtgtcgtgagatgttgggttaagtcccgcaa

[0066] cgagcgcaacccttattgttagttgccagcattcagatgggcactctagcgagactgccggtgacaaaccggaggaaggcggggac

[0067] gacgtcagatcatcatgccccttatgacctgggctacacacgtgctacaatggcgtatacaacgagttgccaacccgcgagggtgagc

[0068] taatctcttaaagtacgtctcagttcggattgtagtctgcaactcgactacatgaagtcggaatcgctagtaatcgcggatcagcacgccg

[0069] cggtgaatacgttcccgggtcttgtacacaccgcccgtcacaccatgggagtttgtaatgcccaaagccggtggcctaaccttttagga

[0070] aggagcc.

[0071] 3. Whole genome sequencing

[0072] The bacteria obtained from liquid culture were sequenced to obtain the complete genome sequence of the bacteria. The genome sequence has been uploaded to the NCBI gene database, and the GenBank accession number is CP150094.

[0073] In summary, combined with the colony morphology, physiological and biochemical characteristics of strain DM12 and the results of molecular biological identification, strain DM12 was determined to be a new strain of Leuconostoc mesenteroides, and was named Leuconostoc mesenteroides DM12.

[0074] Example 3

[0075] Mitigating biological toxicity caused by exposure to dibutyl phthalate

[0076] 1. Grouping and treatment of experimental animals

[0077] After one week of adaptation, 40 Kunming mice were randomly divided into 4 groups: control group (CK group), Leuconostoc mesenteroides DM12 group (DM12 group), dibutyl phthalate exposure group (DBP group), and Leuconostoc mesenteroides DM12 and dibutyl phthalate co-treatment group (DM12+DBP group). The control group was gavaged with PBS buffer every day, and the experimental group was gavaged with the corresponding solution for 28 days. During the gavage, the weight of the mice was recorded, and the feces were collected for the determination of dibutyl phthalate excretion. After the gavage, the mice were killed by cervical dislocation, and serum, organ tissues, sperm, etc. were collected for subsequent analysis.

[0078] 2. Weight change monitoring

[0079] During the intragastric administration, the mice were weighed on days 0, 4, 8, 12, 20, and 28 to observe the changes in their body weight.

[0080] The experimental results are as follows Figure 2 As shown, there was no significant difference in body weight among the four groups of mice in the first 7 days, but after the 8th day, the body weights of the four groups of mice changed significantly, among which the weight gain of mice in the DM group was the fastest, significantly higher than that of the other three groups, followed by the CK group and the DM12+DBP group. The weight gain of mice in the DBP group was the slowest compared with the other three groups, indicating that DBP caused slow weight gain in mice, while Leuconostoc mesenteroides DM12 could restore the normal weight of mice.

[0081] 3. Organ coefficient

[0082] After 28 days, the mice were killed by cervical dislocation, and the liver and reproductive organs of the mice were collected and weighed. The organ coefficient of the mice was calculated by the following formula.

[0083] Organ coefficient = organ weight / mouse weight

[0084] The organ coefficient is a commonly used indicator in toxicological experiments. An increase in the organ coefficient indicates organ congestion, edema, or hypertrophy; a decrease in the organ coefficient indicates organ atrophy and other degenerative changes. The main target organs of dibutyl phthalate are reproductive organs, and the liver is a metabolic organ of the body, so the reproductive organs and liver were selected for analysis. Figure 3 It can be seen that the testis coefficient and liver coefficient of the DBP group were significantly lower than those of the other three groups, and there was no significant difference between the DM12+DBP group and the CK group and the DM12 group, indicating that after DBP exposure, the liver and reproductive organs of mice were damaged to a certain extent, and DM12 alleviated this damage.

[0085] 4. Determination of dibutyl phthalate content in serum and feces

[0086] Feces and blood were collected, and after pretreatment of the samples, the DBP content in serum and feces was determined by high performance liquid chromatography.

[0087] 4.1 Extraction of DBP from serum

[0088] First, thaw the sample frozen at -80℃ in a 4℃ refrigerator, then take 0.1mL of serum into a test tube, add 0.5mL of methanol, 0.1mL of 50wt% phosphoric acid aqueous solution and 0.5mL of ether respectively, centrifuge at 4℃ (10000×g, 10min), take the supernatant, and finally evaporate the organic phase in a fume hood and pass it through a membrane and apply it to the machine.

[0089] 4.2 Extraction of DBP from feces

[0090] First, weigh 1 g of feces into a test tube, add 2 mL of ultrapure water, and incubate at 37°C overnight. Then add 2 mL of methanol solution, stir well, place in a 37°C water bath for 2 h, perform ultrasonic extraction for half an hour, let stand for 1 h, and finally centrifuge (4000 r / min, 10 min), and filter the supernatant.

[0091] The experimental results are as follows Figure 4 As shown in the figure, DBP was not detected in the serum and feces of the CK group and the DM12 group. The DBP content in the serum of the DBP group was significantly higher than that of the DM12+DBP group, and the DBP content in the feces was significantly lower than that of the DM12+DBP group. The average daily DBP excretion was significantly lower than that of the DM12+DBP group (DM12 promoted the excretion rate of DBP in the feces of mice by 43.1%). This shows that DM12 can promote the excretion of DBP, reduce its accumulation in the body, and thus alleviate the harm caused to mice after DBP exposure.

[0092] 5. Determination of sperm quality

[0093] After killing the mice, the epididymis was removed and cut open longitudinally from the tail with ophthalmic scissors and placed in 2 mL of 37°C saline. After 20 minutes, the tissue membrane was removed to prepare a sperm suspension. Sperm density and sperm deformity rate were then measured.

[0094] 5.1 Determination of mouse sperm density

[0095] After the sperm suspension is placed in a 56℃ water bath for 5 minutes, 10μL is dropped on the red blood cell counting plate and observed under a microscope. The sperm density is calculated using the red blood cell counting method. In order to avoid excessive errors, the difference between the maximum and minimum sperm counts recorded in the selected grid should not exceed plus or minus 10%. The calculation formula is as follows:

[0096] Sperm density = the sum of the number of sperm in the 5 middle boxes / 80 × 400 × 10000 × dilution factor

[0097] 5.2 Analysis of mouse sperm deformity rate

[0098] Let the sperm suspension stand for 3-5 minutes and then shake it gently, then filter it. The filtration can be done by lens paper filtration. Take a smear of the filtrate, and after drying, fix it with methanol for more than 5 minutes, then add eosin stain to the glass slide, stain for 15-20 minutes, dry naturally, and rinse with water to dry. After the preparation is completed, first look under a low-power microscope, and then observe the area where the sperm overlaps less and the field of vision is clearer. Observe 400 sperm for each mouse. The possible shapes of sperm include hookless, banana-shaped, amorphous, fat-headed, double-headed, double-tailed, curly-tailed, etc. The formula for calculating the sperm deformity rate is as follows:

[0099] Sperm deformity rate = total number of sperm deformities / total number of observed sperm × 100%

[0100] The experimental results are shown in Figure 5 , sperm count: DM12+DBP group, DM12 group>CK group>DBP group; sperm deformity rate: DBP group>CK group>DM12+DBP group, DM12 group. It can be seen that after DBP exposure, sperm density decreased and deformity rate increased. After DM12 and DBP co-exposure, sperm count and deformity rate returned to normal levels. This shows that DBP reduces sperm production in mice, increases teratogenicity, and causes reproductive toxicity in mice, while DM12 can alleviate toxicity and restore it to normal levels.

[0101] 6. Histopathological section analysis

[0102] The mice were killed by cervical dislocation, and the liver and reproductive organs were fixed in 4wt% paraformaldehyde, dehydrated with gradient ethanol, transparentized with xylene, and then embedded in paraffin, stained with hematoxylin-eosin, and finally observed by histopathological sections.

[0103] The results of reproductive organ pathology are as follows Figure 6 As shown in the figure, the seminiferous tubules in the reproductive organs of the control group were arranged neatly, with normal structure, densely distributed spermatogonia, relatively abundant, and a large number of mature sperms were seen in the lumen; the seminiferous tubules in the DM12 group were arranged regularly, and the spermatogenic cells were clearly layered, with no significant difference from the control group; while in the DBP-exposed group, the spermatogenic cells were arranged disorderly, the number decreased, the cavities increased, the sperm decreased, and the basement membrane of the spermatogenic epithelium became thinner; although the cavities of the DM12 and DBP co-exposed group increased, compared with the DBP group, the basement membrane of the spermatogenic epithelium became thicker, the spermatogonia were arranged tightly, the number increased, and the sperm increased. This shows that after DBP exposure, the reproductive organs of mice were damaged, and after DM12 treatment, the damage to the reproductive organs could be alleviated to a certain extent.

[0104] Liver pathology results Figure 7 As shown in the figure, the hepatocytes in the CK group and DM12 group were closely arranged, with normal structures and no obvious lesions; while in the DBP group, the hepatocytes were disorderly arranged, vacuolated, and the hepatic sinusoids were significantly dilated, with more serious damage; in the DM12+DBP group, the hepatocytes were arranged normally and the liver damage was alleviated. This indicates that DBP caused liver toxicity in mice, and Leuconostoc mesenteroides DM12 could alleviate DBP-induced liver toxicity.

[0105] In summary, foodborne Leuconostoc mesenteroides DM12 can promote the excretion of DBP from mice, reduce its content in serum, significantly reduce the damage of DBP to the reproductive organs and liver of mice, and provide a basis for repairing the body damage caused by plasticizers.

[0106] The Leuconostoc mesenteroides DM12 provided by the present invention can be used alone as a probiotic, or can be used in combination with probiotics such as Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus helveticus, Streptococcus thermophilus, Lactobacillus rhamnosus, Lactobacillus paracasei, Lactobacillus brevis, Bifidobacterium longum, Bifidobacterium infantis, Bacillus coagulans, Lactococcus, Lactobacillus crispatus, Lactobacillus reuteri, Lactobacillus casei, Pediococcus pentosaceus, Lactobacillus bulgaricus, Lactobacillus gasseri, Streptococcus thermophilus, etc., to maintain human or animal health, thereby expanding the application field of probiotics and having extremely high application value.

[0107] The above embodiments describe the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions are only for illustrating the principles of the present invention. Without departing from the scope of the principles of the present invention, the present invention may have various changes and improvements, and these changes and improvements all fall within the scope of protection of the present invention.

[0108]

Claims

1. A strain of Leuconostoc mesenteroides capable of alleviating the toxic effects of plasticizers, characterized in that: Its classification name is Leuconostoc mesenteroides and it is deposited in the General Microbiology Center of China Microbiological Culture Collection Administration with the deposit number: CGMCC NO.30178.

2. The Leuconostoc mesenteroides having the ability to alleviate the toxicity of plasticizers according to claim 1, characterized in that: The Leuconostoc mesenteroides is isolated and purified from kimchi, and its 16s rDNA sequence is shown in SEQ ID NO.1 in the sequence table.

3. The Leuconostoc mesenteroides having the ability to alleviate the toxicity of plasticizers according to claim 1, characterized in that: The Leuconostoc mesenteroides can grow on MRS agar culture medium. The Leuconostoc mesenteroides is a Gram-positive bacterium with a round colony morphology, a smooth surface, and a milky white color. The optimal growth temperature is 37° C. and the culture time is 12 hours.

4. Use of the Leuconostoc mesenteroides described in any one of claims 1 to 3 in the preparation of a biological preparation for preventing or alleviating biological toxicity caused by plasticizers, wherein the Leuconostoc mesenteroides can colonize in the body for a long time, and is used to adsorb plasticizers in the body, promote the discharge of plasticizers in the body, reduce the accumulation of plasticizers in the body, and thus alleviate the biological toxicity of plasticizers.

5. The use according to claim 4, characterized in that: The Leuconostoc mesenteroides can promote the excretion of plasticizers from the body, reduce the content of plasticizers in serum, significantly reduce the damage of plasticizers to reproductive organs and liver, and is used to repair body damage caused by plasticizers.

6. The use according to claim 4, characterized in that: The plasticizer is one or more of dibutyl phthalate, di(2-ethylhexyl) phthalate, dimethyl phthalate, diisobutyl phthalate, dioctyl phthalate, butyl benzyl phthalate, diisononyl phthalate or diethyl phthalate.

7. The use according to claim 4, characterized in that: The plasticizers are taken in from food.

8. The use according to claim 4, characterized in that: The effective dose of dibutyl phthalate for Leuconostoc mesenteroides is 6 mg / kg / d; the number of live bacteria used for Leuconostoc mesenteroides is 5×10 11 CFU / mL.

9. A probiotic preparation, characterized in that: The probiotic preparation comprises the live bacteria of Leuconostoc mesenteroides and / or its fermentation product according to any one of claims 1 to 3.

10. The probiotic preparation according to claim 9, characterized in that: The probiotic preparation also contains one or more of Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus delbrueckii, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus helveticus, Streptococcus thermophilus, Lactobacillus rhamnosus, Lactobacillus paracasei, Lactobacillus salivarius, Leuconostoc lemon, Lactobacillus brevis, Bifidobacterium longum, Bifidobacterium infantis, Bifidobacterium breve, Bifidobacterium bifidum, Bacillus coagulans, Lactococcus, Lactobacillus crispatus, Lactobacillus reuteri, Lactobacillus casei, Pediococcus pentosaceus, Lactobacillus bulgaricus, Lactobacillus gasseri or Streptococcus thermophilus.